Genesis II
Payments companies reported to CMS as associated with Genesis II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Genesis II, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Genesis II
These are the largest totals companies reported as associated with Genesis II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaime Carvajal Alba | Clermont, FL | Orthopaedic Surgery | $36,195.98 |
| Gary Rasmussen | Murray, UT | Adult Reconstructive Orthopaedic Surgery | $3,223.30 |
| Anton Kurdin | Yuba City, CA | Adult Reconstructive Orthopaedic Surgery | $88.81 |
| Gary Okamura | Honolulu, HI | Orthopaedic Surgery | $44.90 |
| Ritesh Shah | Morton Grove, IL | Orthopaedic Surgery | $38.07 |
Prescribed Genesis II?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.